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Vascular networks were created with endothelial colony-forming cells de-
rived from cord blood.
Results: MSCs from various tissue sources demonstrated appropriate
stem cell markers via flow cytometry. P-MSCs exhibited increased apoptosis
in response to H2O2 compared with ASCs and BM-MSCs (P .001). ASCs
demonstrated increased apoptosis after exposure to TNF- and hypoxia
compared with MSCs (P  .001). No difference in senescence activity was
detected by various MSCs. ASCs demonstrated elevated overall survival in
response to H2O2 (P  .05). BM-MSCs and P-MSCs exhibited increased
survival after exposure to TNF- and hypoxia (P .001). ASCs exhibited no
difference in tube formation after exposure to H2O2 compared with con-
trols. However, ASCs exhibited significant decreases in mean tube length
after exposure to TNF- and hypoxic conditions compared with controls
(P  .05).
Conclusions: ASCs remain potent under oxidative stress conditions,
whereas P-MSCs and BM-MSCs thrive under inflammatory and hypoxic
conditions. This report outlines how MSCs respond to various conditions
unique to vascular injury and indicate that ASCs may be the optimal cell
source in critical limb ischemia, because oxidative stress is the dominant
factor determining cell viability in this condition.
Clinical Evaluation of Suspected DVT Guides the Decision to Prophy-
lactically Anticoagulate but Does Not Impact the Decision to Perform
After-Hours Duplex Venous Scanning or Increase Its Yield
Michael R. Go, MD, Dennis Kiser, Patrick Wald, Mounir J. Haurani, MD,
Mark Moseley, MD, and Bhagwan Satiani, MD. Department of Surgery,
The Ohio State University, Columbus, Ohio
Objectives: The utility of after-hours duplex venous scanning (DVS)
for suspected DVT in emergency department (ED) patients has been de-
bated. Availability of safe, prophylactic, low-molecular-weight heparin, cost
containment efforts, and retention of scarce sonographers have to be bal-
anced against 24/7 demand for services. We determined the incidence of
DVT in DVS ordered after hours, correlation between the Wells score and
prophylactic anticoagulation, as well as urgently performed DVS, and com-
plications of delaying DVS until regular hours.
Methods: Records of all ED encounters between July 1, 2009 and
June 30, 2010 associated with a DVS ordered after hours were reviewed.
The decisions to prophylactically anticoagulate andwhether to performDVS
urgently or delayed until regular hours were at the discretion of the ED
physician and a vascular surgeon. DVS findings, number of urgent and
delayed studies, the Wells scores, D-dimer levels, and outcomes were re-
corded.
Results: DVT was found in 12% (n  22) of 181 DVS ordered after
hours. DVT was found in 19% of 42 DVS done urgently and in 10% of 139
DVS delayed an average 10 hours 17 minutes (P  NS). Wells scores were
available for all patients and D-dimer levels for 43 (Table). Seventy-eight
percent of patients with a Wells score 3 had prophylactic anticoagulation,
whereas only 40% of patients with a Wells score 3 had prophylactic
anticoagulation (P .0001). In contrast, 36% of patients with a Wells score
 3 had urgent DVS and 20% of patients with a Wells’ score3 had urgent
DVS (p  ns). Prophylactic anticoagulation was given to 86% of patients
eventually found to have DVT versus 40% of patients eventually found to
have no DVT (P  .0001). There were no PEs or bleeding complications.
Conclusions: The incidence of DVT in ED patients who had urgent
after hours DVS was no different than in those whose DVS was delayed until
regular hours. High pretest probability can be achieved with clinical evalu-
ation prior to DVS, and this guided the decision to prophylactically antico-
agulate but did not impact the decision to perform urgent DVS. Most
patients eventually found to have DVT did receive prophylactic anticoagu-
lation, and delay of DVS did not result in complications. We believe that
most patients in whom there is high clinical suspicion for DVT can safely get
prophylactic anticoagulation and delayed DVS. Patients in whom there is
low clinical suspicion should not get urgent DVS.
Table. Wells score and D-dimer results
Variable Wells score  3 (%) D-dimer (%)
Sensitivity 64 100
Specificity 88 17
Positive predictive value 42 9
Negative predictive value 95 100
Asymptomatic 50% to 75% Internal Carotid Artery Stenosis in 288
Patients: Risk Factors for Disease Progression and Ipsilateral Neuro-
logic Symptoms
Anahita Dua, MD, Bhavin Patel, SreyRam Kuy, MD, Gary Seabrook, MD,
Kellie Brown, MD, Brian Lewis, MD, and Peter Rossi, MD. Medical
College of Wisconsin, Milwaukee, Wisc
Objectives: This study evaluated the safety of an observation protocol
in asymptomatic patients with moderate internal carotid artery stenosis, and
to identify characteristics associated with disease progression.
Methods: Patients with asymptomatic moderate internal carotid dis-
ease (peak systolic velocity [PSV]  125 cm/s and end diastolic velocity
[EDV] 125 cm/s by duplex ultrasound imaging) correlating to 50% to
75% diameter reduction were monitored for 3 years. Progression to greater
than 75% diameter reduction (EDV 125 cm/s) or presentation with focal
neurologic symptoms (stroke, amaurosis fugax, transient ischemic attack)
was documented. Comorbidities, smoking status, and medications were
recorded. Log-rank testing, Wilcoxon models, and Kaplan-Meier plots
provided statistical analysis.
Results: During follow up, 26 of 288 patients (9%; 137 men, 151
women) developed symptoms (stroke: 9 [3.1%]; transient ischemic attack: 3
[1%]; amaurosis fugax: 3 [1%]), or asymptomatic increase in diameter to
75% (11 patients [3.8%]). All-cause mortality was 11% (33 patients).
Seventeen patients (5.9%) underwent carotid endarterectomy and five
(1.7%) had carotid stent placement. The event incidence was significantly
higher for men (P .02), but survival was not different. The rate of disease
progression or development of symptoms was 5.5% at 12 months and
increased to 7.2% by 24 months. Comorbidities with the highest associated
event incidences were coronary artery disease (8.1%), hyperlipidemia (7.3%),
and hypertension (6.7%). Medications associated with lower event inci-
dences were insulin (2.8%) and angiotensin-receptor blockers (1.9%).
Conclusions: Sequential surveillance of asymptomatic patients with
moderate carotid disease is safe, with only 5% becoming symptomatic and 4%
having disease progression. Male patients with coronary artery disease,
hyperlipidemia, and hypertension are at increased risk and are candidates for
frequent screening and/or early intervention.
Deep Venous Thrombosis After Saphenous Endovenous Radiofre-
quency Ablation: Is It Predictable?
Maria C.Mora, MD, Peter JBHunt, MD, Jennifer Orozco, Chad E. Jacobs,
MD, Aksim Rivera, MD, and Walter J. McCarthy, MD. Rush University
Medical Center, Chicago, Ill
Objectives: Endovenous radiofrequency ablation (RFA) is a safe and
effective treatment for varicose veins secondary to saphenous reflux. Deep
venous thrombosis (DVT) is a known complication of this procedure. The
purpose of this study is to describe the frequency of DVT after RFA and
associated predisposing factors.
Methods: We performed a retrospective data analysis from December
2008 to December 2011, during which 277 consecutive office-based RFA
were performed in our institution using the VNUS ClosureFast catheter.
Duplex scans were completed 2 weeks postprocedure in all patients to
confirm saphenous vein obliteration and evaluate the deep venous system for
thrombosis. Risk factors assessed for development of DVT included greater
vs lesser saphenous, side treated, number of cycles used, hypercoagulable
state, history of DVT, tobacco use, medications (oral contraceptives, aspirin,
warfarin, clopidogrel), and vein diameter at the junction of the superficial
and deep systems.
Results: Seventy percent of the patients were female, 56% were right
side, and 86% were performed on the greater saphenous vein. Mean age was
54  14 (range, 23-88 years). 3% of patients had a diagnosis of hypercoag-
ulable state and 8% had a history of DVT. Follow-up ultrasound imaging
showed thrombus protrusion into the deep system without occlusion was
present in 11 patients (4%). DVT, as defined by thrombus protrusion with
complete occlusion of the femoral or popliteal vein, developed in two
patients (0.7%). PreviousDVTwas the only factor associated withDVT (P
.018). Although not statistically significant, there was a trend toward higher
risk of DVT in LSV patients. Factors associated with protrusion into the
deep system were lesser saphenous vein (P  .035), and factor V Leiden
(P  .026).
Conclusions: The use of RFA to treat patients with saphenous reflux
involves a small but definite risk of DVT. This study demonstrates that the
risk of DVT or any thrombus protrusion in to the deep system is greater in
patients with previous DVT, factor V Leiden, and treatment of the lesser
saphenous vein. Periprocedural anticoagulation should be considered in this
subset to reduce the risk of complication after RFA.
Response of Neointimal Hyperplasia and the Adventitial Sca1 Stem
Cell to Nitric Oxide
Nathaniel C. Koo, MD, George E. Havelka, MD, Janet Martinez, Megan
Flynn, and Melina R. Kibbe, MD. Northwestern University, Chicago, Ill
Objectives:Recently, Sca1 stem cells have been identified to reside in
the adventitia of the arterial wall. However, their role in the formation of
neointimal hyperplasia is unknown, as is the effect of nitric oxide (NO) on
these cells. We hypothesize that Sca1 stem cells contribute to neointimal
development and that NO limits the involvement of adventitial Sca1 cells
in the arterial injury response, thereby inhibiting neointimal hyperplasia.
JOURNAL OF VASCULAR SURGERY
Volume 56, Number 4 Abstracts 1185
Methods: The mouse femoral artery wire injury model was performed
in 10-week-old male C57BL/6 mice. Treatment groups included control,
injury, and injuryNO (n 5/group). Arteries were harvested at 24 hours,
3 days, 7 days, and 2 weeks after injury and assessed for Sca1 cells using
immunofluorescence. Sca1 staining was graded on a scale of 0 to 4 for the
intima, media, and adventitia in four high-power fields per section.
Results: Sca1 staining in the adventitia after injury significantly
decreased at 24 hours (1.9  0.13, P  .001) and 3 days (1.9  0.12, P 
.001) and returned to baseline by 2 weeks. Sca1 staining in the media after
injury significantly increased by 7 days (2.3 0.23), and persisted to 2 weeks
(2.4 0.19) after injury (P .001). Sca1 staining in the intima after injury
also significantly increased by 7 days (3.0  0.14) and persisted to 2 weeks
(2.7 0.14) after injury (P .001). In the adventitia, NOhad no significant
effect on Sca1 levels. However in the media, NO significantly decreased
Sca1 levels at 7 days (1.5 0.19) vs injury alone (P .002). In the intima,
NO significantly decreased Sca1 levels at 7 days (2.2  0.23) and 2 weeks
(2.3  0.18) vs. injury alone (P  .001 and P  .03, respectively).
Conclusions: The level of resident Sca1 stem cells decreases in the
adventitia after arterial injury and then increases in the media and neointima,
suggesting that Sca1 stem cells contribute to the formation of neointimal
hyperplasia. NO decreases Sca1 levels in the intima and media after injury,
suggesting one mechanism by which NO may inhibit the formation of
neointimal hyperplasia. Together, these data suggest an important role of
Sca1 stem cells in the arterial injury process. Identification of the mecha-
nism of Sca1 inhibition by NO could lead to a therapy to prevent neoin-
timal hyperplasia.
Patients With Chronic Obstructive Pulmonary Disease Have Shorter
Survival but Superior Endovascular Outcomes After Endovascular
Aneurysm Repair
Moqueet A. Qureshi, MD, Roy K. Greenberg, MD, Tara M. Mastracci,
MD, Matthew J. Eagleton, MD, and Adrian V. Hernandez, PhD. Vascular
Surgery/Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio
Objectives: This study was conducted to determine the effect of
pulmonary disease on outcomes after endovascular abdominal (EVAR) and
thoracoabdominal (eTAAA) aneurysm repair.
Methods: A prospective study of high-risk patients undergoing EVAR
and eTAAA repair between 1998 and 2009 was used to contrast clinical and
endovascular outcomes between chronic obstructive pulmonary disease
(COPD; group 1) and non-COPD patients (group 2). COPD patients were
classified in accordance with the severity of their pulmonary disease using the
criteria. Survival, morphologic changes, and complications were assessed
using Cox models and life-table analyses. The cause and timing of deaths
between the groups was compared.
Results:A total of 905 patients were analyzed, of which 289 (32%) had
COPD. EVAR was performed in 334 patients (37%), whereas fenestrated/
branched devices were used in the remaining 571 (63%). Group 1 patients
were younger (73.5  6.7 vs 75.6  8.2 years), had a better glomerular
filtration rate (67.8  25.8 vs 61.0  23.3 mL/min/1.73 m2), had higher
hematocrits (41.6 5.0 vs 40.5 4.6), and had more extensive aneurysms.
Mean follow-up was 39.5  30.9 months. Early (3% vs 3%) and late (2% vs
1%) aneurysm-related deaths were similar between the two groups. Survival
in group 1 was lower than that in group 2 (P .0001; Fig 1). Furthermore,
survival in group 1 was dependent upon the severity of disease, with Global
Initiative for Chronic Obstructive LungDisease classification I and II similar
to group 2, and classifications III and IV demonstrating lower survival rates
(P  .0001; Fig 2). Relevant pulmonary function test variables included a
lower forced expiratory volume in 1 second and forced expiratory flow
25%-75%, which were associated with decreased survival. Surrogate endo-
vascular outcome analyses demonstrated that group 1 patients had fewer
endoleaks (20% vs 25%, P  .05) and more rapid sac shrinkage rate (1.66
mm/y difference, P  .001).
Conclusions: The perioperative risk of mortality between COPD and
non-COPD patients is eliminated when endovascular techniques are used.
Long-term survival in COPD patients is most strongly related to the severity
of their disease, and forced expiratory volume in 1 second and forced
expiratory flow 25%-75%, are reasonable indicators of poor long term
outcomes. Morphologic changes following EVAR and eTAAA repair are
more favorable in COPD patients, with a lower endoleak rate and faster sac
shrinkage.
Are Lower Extremity Endovascular Procedures Associated with Fewer
Hospital Readmissions?
ToddR.Vogel,MD,Robin L. Kruse, PhD, andW.KirtNichols,MD. University
ofMissouri Hospitals and Clinics, Columbia, Mo
Objectives: As pressure to contain health care costs increases, there has
been greater scrutiny of readmissions in the vascular surgery population. The
objective of this study was to evaluate postoperative readmissions after open
(OPEN) and endovascular (ENDO) lower extremity (LE) procedures for
PAD (peripheral artery disease).
Methods: Inpatients with PAD and LE procedures were selected from
the Cerner Health Facts database between October 2008 and December
2010, using International Classification of Diseases-9 Edition-ClinicalMod-
ification diagnosis codes (claudication, rest pain, and ulceration/gangrene)
and procedure codes for LE revascularization (ENDO and OPEN). Read-
mission30 days of discharge was determined. Charlson comorbidity index
was used to adjust for comorbidities, and 2 and multivariable logistic
regression were used to compare patients who received ENDO and OPEN
procedures.
Results:Of 453,257 index admissions, 10,103 patients were identified
with a diagnosis of PAD. Combining PAD with elective LE procedures
during the index admission, 657 and 678 underwent OPEN and ENDO,
respectively. Overall readmission rates or OPEN and ENDO for claudica-
tion, rest pain, and ulceration/gangrene were 9.68% vs 12.50% (P  .29),
14.29% vs 18.60% (P  .38), and 17.9% vs 20% (P  .60); respectively.
Readmission increased by the severity of the diagnosis for both OPEN and
ENDO (P  .0001). Men comprised 59% of the cohort, and readmission
rates were not statistically different by sex (P .25). Race was not associated
with procedure performed (P  .7). After adjustment for age, race, sex,
comorbidities, and procedure, patients with ulceration/gangrene (odds
ratio [OR], 1.7; 95% confidence interval [CI], 1.17-2.41), non-Caucasian
race (OR, 1.5; 95% CI, 1.08-2.19), and increased numbers of comorbidities
(OR, 1.1; 95% CI, 1.01-1.22) were more likely to be readmitted. Diagnoses
at readmission were similar between groups.
Conclusions: Less invasive endovascular procedures were not associ-
ated with decreased readmission rates compared with open surgery. Read-
mission rates for claudicants were unexpectedly high, with an overall rate of
11%. Predictors of readmission included black race and increased severity of
disease. Further examination exploring reasons for readmission are required
to decrease readmission rates in the vascular surgery population.
Midterm Results of Replacement of Synthetic Graft and Arterial Infec-
tion in the Groin With Femoropopliteal Vein
Amanda J. Kravetz, MD. Department of Vascular and Endovascular Sur-
gery, Mayo Clinic, Rochester, Minn. Sponsored by: Manju Kalra, MD,
Rochester, Minn.
Objectives: Infection of synthetic grafts or femoral arteries in the groin
is a challenging problem to treat. Femoropopliteal vein (FPV) is an ideal
conduit, but extensive replacement of infected aortic grafts with FPV has
been associated with significant morbidity. The aim of this study was to
evaluate early and long-term outcome of limited replacement with FPV of
infected femoral arteries/grafts in the groin.
Methods: Data from 37 patients who underwent excision of infected
femoral grafts and replacement with FPV over an 18-year period from 1994
to 2012 were retrospectively analyzed.
Results: Surgical intervention was performed in 41 limbs of 27 men
and 10 women (mean age, 67.5 years) at a median of 2.5 years after the
original synthetic implantation (aortofemoral n 21, femorofemoral n 3,
femorodistal n 5, patch angioplasty n 2) or, on average, 22.2 days after
cardiac catheterization (n  6) and one mycotic aneurysm. Presentation
included draining sinus (n  7), abscess (n  4), persistent fevers (n  6),
and pseudoaneurysm (n  10; intact, 4; ruptured, 6). Twenty-five patients
Fig.
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